Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArmadale Capital Regulatory News (ACP)

  • There is currently no data for ACP

Total Voting Rights

31 Jul 2007 11:33

MicroFuze International plc31 July 2007 For Immediate Release 31 July 2007 MicroFuze International plc ("MicroFuze" or "the Company") TOTAL VOTING RIGHTS In accordance with the FSA's Disclosure and Transparency Rules, the Companywould like to notify the market of the following: • MicroFuze's share capital consists of 224,369,110 ordinary shares with voting rights. The Company holds no shares in treasury. • Therefore, the total number of voting rights in the Company is 224,369,110. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, MicroFuze under the FSA'sDisclosure and Transparency Rules. - END - Enquiries: Nominated Adviser:Nabarro Wells & Co. LimitedHugh Oram/John Wilkes Tel: +44 (0) 20 7710 7400 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Apr 202110:00 amRNSCompletion of Test Work Program
12th Apr 20219:20 amRNSChange of Adviser
30th Mar 20219:58 amRNSESIA Approval from NEMC of Tanzania
24th Mar 20217:35 amRNSBoard Change
8th Mar 202112:36 pmRNSNotification of Changes in Major Holdings
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 202111:00 amRNSArmadale Reports Successful Chinese EPC Test-Work
11th Jan 202111:00 amRNSCSIRO Graphite Test Work Results
17th Dec 20207:00 amRNSBlock listing Interim Review
24th Nov 202012:03 pmRNSTest-Work Commenced with Leading EPC Contractor
20th Nov 20204:41 pmRNSSecond Price Monitoring Extn
20th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 202010:00 amBUSMahenge Graphite Project Update
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:36 pmRNSPrice Monitoring Extension
29th Sep 20208:46 amBUSHalf-year Report
8th Sep 202012:45 pmBUSEnvironmental and Social Impact Assessment Submitted
13th Aug 20201:15 pmBUSAssessment of Mahenge Natural Flake Graphite for Battery Applications
16th Jul 202011:43 amBUSUpdated Corporate Presentation
2nd Jul 202010:45 amBUSMining Licence Application Submitted
30th Jun 202010:30 amBUSAGM Statement
18th Jun 202012:00 pmBUSBlock Admission
15th Jun 202010:00 amBUSProject Finance Update
8th Jun 20202:00 pmRNSPrice Monitoring Extension
8th Jun 202011:45 amBUSConversion of CLNs, Exercise of Warrants and Issue of Equity
5th Jun 202011:45 amBUSDFS update increases Mahenge NPV to $430 million
4th Jun 20207:37 amBUSFinal Results and Notice of AGM
29th May 20202:00 pmBUSExercise of Warrants and Issue of Equity
27th May 20202:06 pmRNSSecond Price Monitoring Extn
27th May 20202:00 pmRNSPrice Monitoring Extension
26th May 20207:30 amBUSExercise of Warrants and Issue of Equity
18th May 20207:00 amBUSConversion of CLNs, Exercise of Warrants and Issue of Equity
12th May 202010:00 amBUSUpdated Mine Plan Materially Increases Production
11th May 202010:30 amBUSExercise of Warrants and Issue of Equity
5th May 202011:05 amRNSSecond Price Monitoring Extn
5th May 202011:00 amRNSPrice Monitoring Extension
4th May 202010:45 amBUSExercise of Warrants and Issue of Equity
30th Apr 202010:54 amBUSSubscription
29th Apr 20202:51 pmBUSConversion of Convertible Loan Note
24th Apr 202010:35 amBUSBoard Appointment
16th Apr 202012:45 pmBUSDirectorship Changes
31st Mar 20202:00 pmBUSDFS confirms Mahenge as a long-life low-cost graphite project with US$358m NPV and IRR of 91%
25th Mar 20202:01 pmRNSPrice Monitoring Extension
25th Mar 20201:15 pmBUSTest work produces 97% TGC concentrates
24th Mar 20202:06 pmRNSSecond Price Monitoring Extn
24th Mar 20202:00 pmRNSPrice Monitoring Extension
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
10th Mar 202011:30 amBUSImproved Mine Plan Increases Production Output by 100% via staged ramp-up

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.